Target intelligence / Profile preview

Human Immunodeficiency Virus Type 1 (HIV-1)

Target
HIV-1
Molecular classification
Retrovirus, Virus, RNA virus
01

Overview

Human immunodeficiency virus type 1 (HIV-1) is a retrovirus and the primary causative agent of acquired immunodeficiency syndrome (AIDS). It infects human immune cells, leading to progressive immune system failure and increased susceptibility to opportunistic infections. Key targets within HIV-1 for therapeutic intervention include reverse transcriptase, protease, integrase, gp120, and gp41. The virus hijacks cellular machinery for replication; new virions bud off with portions of the host membrane containing embedded viral glycoproteins. HIV infection leads to depletion of CD4+ T-cells leading toward AIDS.

Other names
HIV 1HIVAIDS Virus
02

Mechanism of action

Varies depending on the targeted protein; includes inhibition of reverse transcription, protease activity, integrase activity, viral entry, and CD4 attachment.

03

Biological functions

Viral replicationImmune suppressionCell entryReverse transcriptionIntegrationBudding
04

Disease associations

AIDSOpportunistic infectionsImmunodeficiencyInfection
05

Safety considerations

Drug resistanceAdverse drug effects (e.g., lipodystrophy, nephrotoxicity)Immune reconstitution inflammatory syndrome (IRIS)Long-term toxicity of antiretroviral therapy
06

Interacting drugs

Reverse transcriptase inhibitors (e.g., Zidovudine, Nevirapine)

5 more in the full profile.

07

Biomarkers

Viral load (HIV-1 RNA levels)CD4+ T-cell countDrug resistance mutations

Beyond the preview

Go deeper on Human Immunodeficiency Virus Type 1 (HIV-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human Immunodeficiency Virus Type 1 (HIV-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call